Loading
Latest filing published 09 Mar 2023 for F-star Therapeutics, Inc., €30k.
No signal scores available.
Edward Benz Jr. discloses dealings in F-star Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 1 February 2021 to 8 March 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 9 March 2023: a transaction of €30k, in F-star Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations